Table 4 Percentage (95% CI) of Chinese adults meeting the definition for recommended antihypertensive medication according to the 2017 ACC/AHA Guideline and the 2010 China Hypertension Guideline based on the 2011 China Health and Nutrition Survey (n = 12,499)
Recommended antihypertensive medication | Difference (2017 ACC/AHA but not 2010 Chinese Hypertension Guideline) | ||
|---|---|---|---|
2017 ACC/AHA Guideline | 2010 Chinese Hypertension Guideline | ||
Overall | 31.5(30.7,32.3) | 28.8(28.0,29.6) | 2.7(2.4,3.0) |
Age, years | |||
18–34 | 5.0(4.0,5.9) | 5.0(4.0,5.9) | 0.0(0.0,0.0) |
35–44 | 12.4(11.1,13.8) | 12.3(11.0,13.7) | 0.1(0.03,0.2) |
45–54 | 27.2(25.6,28.9) | 27.2(25.6,28.8) | 0.0(0.0,0.0) |
55–64 | 40.1(38.4,41.9) | 39.6(37.9,41.4) | 0.5(0.2,0.7) |
65–74 | 64.3(62.0,66.7) | 50.9(48.5,58.4) | 13.4(11.7,15.1) |
≥ 75 | 68.8(65.6,72.0) | 52.2(51.8,58.6) | 13.6 (11.2,16.0)b |
Sex | |||
Men | 33.9(32.7,35.2) | 31.1(29.9,32.3) | 2.8(2.4,3.3) |
Women | 29.4(28.3,30.5) | 26.8(25.7,27.8) | 2.6(2.2,3.0) |
The history of CVD a | |||
Yes | 85.1(81.1,89.2) | 73.9(69.0,78.9) | 11.2(7.7,14.8) |
No | 30.2(29.4,31.0) | 27.7(26.9,28.5) | 2.5 (2.2,2.8)b |